NeuMoDx SARS-Cov-2 Assay Receives FDA EUA
The assay is a real-time RT-PCR diagnostic for covid-19, detecting SARS-CoV-2 coronavirus RNA from nasopharyngeal, oropharyngeal, and nasal swab specimens.
Read MorePosted by | Apr 6, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The assay is a real-time RT-PCR diagnostic for covid-19, detecting SARS-CoV-2 coronavirus RNA from nasopharyngeal, oropharyngeal, and nasal swab specimens.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
A single unit the size of a shoebox can perform 180 amplification runs per day.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
In a single testing run of about 1 hour, the QIAstat Dx test kit can differentiate the SARS-CoV-2 coronavirus from 20 other serious respiratory infections in patients who may have similar symptoms.
Read MorePosted by | Apr 2, 2020 | Blood Gas Analyzers, Clinical Chemistry, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Already available in countries requiring the CE mark, the RapidPoint 500e blood gas analyzer is now available for critical care testing in the United States.
Read MorePosted by | Apr 2, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
Vela Diagnostics will offer the manual ViroKey SARS-CoV-2 RT-PCR test when validation is completed, which is targeted for early April 2020.
Read More